The purpose of the present study was to evaluate the diagnostic performance of a commercial serum antibody enzyme-linked immunosorbent assay (ELISA) modified to detect anti-Porcine reproductive and respiratory syndrome virus (PRRSV) antibodies in pen-based oral fluid specimens. Experimental and field oral fluid samples of defined status in reference to exposure of swine with PRRSV were used to derive the kinetics of detectable concentrations of antibody against PRRSV. Immunoglobulin (Ig)M and IgA were readily detected in oral fluid specimens from populations in which PRRSV infection was synchronized among all individuals but not in samples collected in commecial herds. In contrast, IgG was readily detected at diagnostically useful levels in both experimental and field samples for up to 126 days. Estimates of the IgG oral fluid ELISA performance were based on results from testing positive oral fluid samples (n = 492) from experimentally inoculated pigs (n = 251) and field samples (n = 241) and negative oral fluid samples (n = 367) from experimentally inoculated pigs (n = 84) and field samples (n = 283). Receiver operating characteristic analysis estimated the diagnostic sensitivity and specificity of the assay as 94.7% (95% confidence interval [CI]: 92.4, 96.5) and 100% (95% CI: 99.0, 100.0), respectively, at a sampleto-positive ratio cutoff of ≥0.40. The results of the study suggest that the IgG oral fluid ELISA can provide efficient, costeffective PRRSV monitoring in commercial herds and PRRSV surveillance in elimination programs.
Introduction
"Oral fluid," the liquid collected by placing an absorptive device in the mouth, 2 is a combination of serum transudate and saliva. Serum transudate enters the mouth from capillaries in the oral mucosa, crevicular gap, and gingival tissues. 5, 8 In human beings, the ease of collecting oral fluid samples has facilitated the implementation of this approach for large epidemiological studies. For example, in England, oral fluid samples were collected from 11,698 children at home by their parents and mailed to the laboratory for antibody testing. 3 Oral fluid specimens are used in human medicine and forensics for the diagnosis or detection of a variety of infectious agents, 23 hormones, 19 and drugs. 7 In particular, the recognition that both Human immunodeficiency virus (HIV) and anti-HIV antibodies were present in oral fluid specimens 1, 11 stimulated assay development. At present, surveillance and monitoring for HIV is commonly done by testing oral fluid specimens using rapid (20-min) point-of-care assays. 25 Although oral fluid testing has not been widely applied to livestock health and wellness management, veterinary literature on the presence of antibodies, pathogens, and acute phase proteins in oral fluids from animals reflects the findings in human beings. 30 In swine, infectious agents, cortisol, acute phase proteins, and progesterone have all been detected in oral fluid specimens under experimental and field conditions. 12, 24, [27] [28] [29] Increasingly, oral fluid samples are used for the surveillance of Porcine reproductive and respiratory syndrome virus (PRRSV) infections in commercial swine operations using polymerase chain reaction (PCR)based assays. 6, 15 While PCR-based assays are useful for detecting the circulation of PRRSV, antibody-based assays are informative regarding herd immunity and history of prior infection. Therefore, the purpose of the present study was to evaluate the diagnostic performance of a commercial serum antibody enzyme-linked immunosorbent assay (ELISA) a modified to detect anti-PRRSV antibodies in oral fluids.
Materials and methods

Experimental design
Oral fluid samples (n = 11) of known PRRSV status (reference standards) were prepared for use in optimizing the antibody isotype-specific PRRSV ELISAs (immunoglobulin [Ig]M, IgA, IgG) and as in-house plate controls. Thereafter, experimental and field samples of defined status were used to describe antibody kinetics (IgM, IgA, IgG) and estimate the diagnostic performance (sensitivity and specificity) of the PRRSV IgG indirect ELISA.
Oral fluid specimens
All procedures for pigs experimentally inoculated with PRRSV or vaccinated with licensed modified live virus (MLV) PRRS vaccine were approved by the Institutional Animal Care and Use Committees (IACUC) at Iowa State University (IACUC no. 10-10-7033-S) and Kansas State University (IACUC no. 4567). In all cases, oral fluid specimens were collected by allowing access to a short length of cotton rope suspended in the pen. After 20-30 min of pig interaction (biting) with the rope, oral fluid was extracted by passing the rope through a hand-operated wringer. b These procedures are fully described elsewhere (National Pork Board: 2011, Oral fluid collection in pigs booklet [NPB-03623]. Available at: http://www.porkstore.pork.org/producer/ default.aspx?p=viewitem&item=NPB-03623&subno=&sho wpage=4&subcat=12. Accessed December 20, 2011).
In brief, 5-week-old pigs (n = ˜1 ,100) in 1 PRRSVnegative, commercial, wean-to-finish barn were intramuscularly vaccinated with 2 ml of a type 2 PRRS MLV vaccine. c Oral fluid was collected from every pen (n = 37) in the barn at 0, 10, 15, 20, 28, 35, 41, 49, 56, 75 , and 91 days postvaccination (DPV). At each collection, the oral fluids were pooled in a single 10-liter container. In the laboratory, the fluid was clarified by centrifugation at 12,000 × g for 8 hr at 4°C and stored (-20°C) in 500-ml volumes. After the entire volume had been processed, the oral fluid was placed in a single 10-liter container, stirred for 30 min to ensure homogeneity, decanted into 50-ml centrifuge tubes, d and stored at -80°C.
Oral fluid samples (n = 693) were collected from pigs inoculated with a type 2 PRRSV (NVSL 97-7895, GenBank accession no. AY545985) under experimental conditions at the Kansas State University BL-2 animal facility (Manhattan, Kansas). Prior to PRRSV inoculation, pigs were confirmed to be free of PRRSV infection by testing serum samples using a commercial semiquantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) kit e and a commercial ELISA, a respectively. In each of 7 trials, approximately two hundred 2-to 3-week-old pigs (15 or 16 pigs per pen) were challenged with 1 × 10 5 TCID 50 of PRRSV. One half of the 3-ml challenge dose was administered intramuscularly, and the remainder was given intranasally. Thereafter, oral fluid samples were collected at 0, 5, 7, 9, 11, 14, 17 , and 21 days postinoculation (DPI) and stored at -80°C.
Expected PRRSV antibody-negative oral fluid field samples (n = 283) for assessing IgG ELISA specificity were selected from samples submitted to the Iowa State University Veterinary Diagnostic Laboratory (ISU VDL, Ames, Iowa) for PRRSV qRT-PCR testing from herds actively monitored for freedom from PRRSV infection. Potential PRRSV antibodypositive oral fluid samples were collected from wean-to-finish barns on 10 sites in a longitudinal field study 31 (n = 600). The 10 sites were sourced from 5 sow sources located in 4 different states (Colorado, Illinois, Oklahoma, and Utah). Most sites (2-4 barns per site) were managed all-in all-out, and the site fill time was 1 or 2 days. Pigs were not vaccinated against PRRSV. At each site, oral fluid samples were collected from the same 6 pens housing approximately 25 pigs per pen at 2-week intervals from placement (˜3 weeks of age) to slaughter. Following the completion of sample collection, the 600 oral fluid samples (6 pens × 10 barns × 10 sampling points) were randomly ordered and tested by qRT-PCR for PRRSV. Expected PRRSV antibody-positive oral fluid field samples for assessing IgG ELISA sensitivity were defined as all samples collected from a pen after its first PRRSV qRT-PCR-positive sample. Among the 600 field samples screened, 241 samples met this definition.
Protocol for PRRSV oral fluid IgG ELISA
The procedure for the commercial indirect ELISA a was modified to detect anti-PRRSV antibody in porcine oral fluid specimens. 14 The modified assay required 2 days to complete. In brief, on day 1, oral fluid samples were diluted 1:2 in dilution plates (150 µl oral fluid sample and 150 µl diluent) using the diluent provided with the test kit. Diluted oral fluid was then transferred to the 96-well PRRSV antigencoated plates (250 µl per well per sample). Negative and positive kit controls were diluted 1:30 using the kit diluent (10 µl kit control and 290 µl diluent), and 100 µl was transferred to the assigned wells on the plates (i.e., A1 and B1 for negative controls; C1 and D1 for positive controls). Thereafter, plates were incubated for 16 hr at 4°C in a refrigerated incubator. At the end of the 16-hr incubation period, the coated plates were washed 3 times with 400 µl of 1× kit wash solution. To detect bound antibody, reagents were brought to room temperature and then 100 µl of a solution containing appropriately diluted horseradish peroxidase (HRP)-conjugated anti-swine IgG FC secondary antibody f was added to each well and incubated for 30 min at 22°C. Thereafter, plates were washed 3 times with wash solution, then 100 µl of tetramethylbenzidine enzyme substrate solution was added to each well, and the plates were incubated at 22°C for 15 min. After 15 min, 100 µl of kit stop solution was added to each well. The plates were read at 650 nm using an ELISA plate reader g controlled by commercial software. h The reactions were measured as optical density (OD) and then converted to sample-topositive ratios (S/P) using the following formula:
where NCxand PCxrepresent the mean OD of the negative control wells and positive control wells, respectively. For the PRRSV oral fluid IgG ELISA results to be valid, the mean of the kit positive control OD minus the mean of the kit negative control OD had to be ≥0.150 and the kit negative control mean OD ≤ 0.150. These validity checks were identical to those required by the manufacturer for the PRRSV serum ELISA.
Preparation of anti-swine IgG FC secondary antibody
The appropriate dilution of HRP-conjugated anti-swine IgG FC antibody f was calculated for each ELISA kit lot to standardize the strength of the reaction and ensure the repeatability of results. This was achieved by determining the dilution of antiswine IgG FC that matched the positive control OD value listed in the manufacturer's Certificate of Analysis for the ELISA kit lot. Certificates of Analysis for specific kit lots can currently be obtained using the manufacturers' Certificate of Analysis Request Form (http://www.idexx.com/view/xhtml/en_us/livestock-poultry/certificates-of-analysis.jsf).
In brief, 4 dilutions (1:1,000; 1:1,500; 1:2,000; 1:2,500) of anti-swine IgG FC antibody f were prepared using the antipig IgG:HRPO conjugate provided with the ELISA a kit as diluent and then stirred for 48 hr at 4°C. To test the reactivity of the 4 dilutions of anti-swine IgG FC , kit negative and positive controls were diluted 1:30 (10 µl kit control and 290 µl kit sample diluent), and then 100 µl of diluted negative control was transferred into 48 wells (i.e., one half of the plate) and 100 µl of diluted positive control in each of the remaining 48 wells. Thereafter, the protocol for the PRRSV oral fluid IgG ELISA was conducted, as described above. Negative control OD values were used to detect nonspecific reactions. Positive control OD values were used to determine the correct dilution of secondary antibody in 2 steps: 1) linear regression (equation 2) was used to determine the equation of the line that described the relationship between positive control OD response and secondary antibody dilution (1:1,000; 1:1,500; 1:2,000; 1:2,500) and 2) the appropriate dilution of conjugated antibody dilution was calculated by substituting the mean positive control OD from the Certificate of Analysis for x into equation 2 and then solving for y:
where y is the OD, a is the slope of the line, x is the dilution of secondary antibody, and c is the intercept.
IgM and IgA protocols
The commercial indirect ELISA was also modified to detect PRRSV-specific IgM (or IgA) antibody responses. To detect bound antibody, HRP-conjugated anti-pig IgM antibody i or anti-pig IgA antibody j was diluted 1:2,000 in conjugate diluent provided by the kit manufacturer. The reference standard oral fluid sample collected on day 0 was used as the negative control. The S/P values for IgM and IgA ELISAs were calculated as described in equation 1 using reference standard samples collected on DPV 10 and 35 used as positive controls for the IgM and IgA ELISAs, respectively.
For the PRRSV oral fluid IgM and IgA ELISA results to be valid, the mean of the kit positive control OD minus the mean of the kit negative control OD had to be ≥0.150 and the kit negative control mean OD ≤0.150. These validity checks were identical to those required by the manufacturer for the PRRSV serum ELISA.
Evaluation of IgG ELISA performance
Receiver operator characteristic (ROC) analyses were performed using MedCalc 9.2.1.0. k Diagnostic sensitivity, specificity, and 95% confidence intervals were estimated for a range of S/P values (≥0.20 to ≥0.40) using test results from samples of defined status. Positive samples for estimating diagnostic sensitivity included oral fluid specimens from experimentally inoculated pigs (n = 251) collected on DPI 14, 17, and 21 and field samples (n = 241) collected from pens following their first PRRSV qRT-PCR-positive oral fluid sample. Negative samples for estimating diagnostic specificity included oral fluid specimens from experimentally inoculated pigs collected on DPI 0 (n = 84) and negative field samples (n = 283). Negative oral fluid field samples were diagnostic samples submitted to the ISU VDL for PRRSV qRT-PCR testing from PRRSVnegative herds with active monitoring programs.
Results
Reference standards
Anti-PRRSV antibody isotype (IgM, IgA, IgG) kinetics in reference standard samples are given in Figure 1 
Experimental samples
Anti-PRRSV antibody isotype (IgM, IgA, IgG) kinetics in experimental samples are shown in Figure 2 for oral fluid samples collected on DPI 0, 5, 7, 9, 11, 14, 17, and 21. Mean IgM, IgA, and IgG S/P ratios on DPI 7 were 1.14 (95% confidence interval [CI]: 1.04, 1.24), 0.09 (95% CI: 0.06, 0.12), and 0.59 (95% CI: 0.50, 0.68), respectively. The mean IgM S/P ratio peaked at DPI 9 (1.88; 95% CI: 1.78, 1.97) and declined rapidly to a mean S/P of 0.10 (95% CI: 0.09, 0.13) on DPI 21. Mean IgA and IgG S/P ratios peaked at DPI 11 (1.41; 95% CI: 1.29, 1.53) and DPI 14 (3.69; 95% CI: 3.52, 3.85), respectively. Mean IgA and IgG S/P ratios remained relatively constant until the end of study at DPI 21. Table 1) .
Field samples
Mean oral fluid IgM, IgA, and IgG S/P ratios at the time of the first detection of PRRSV by qRT-PCR were 0.14 (95% CI: 0.05, 0.23), 0.23 (95% CI: 0.08, 0.38), and 1.98 (95% CI: 1.42, 2.53), respectively (Table 1) . Peak IgM S/P ratios 0.20 (95% CI: 0.07, 0.33) were observed 2 weeks after the first detection of PRRSV by qRT-PCR and declined thereafter. Immunoglobulin A and IgG S/P ratios were relatively steady but tended to increase over the course of the observation period, reaching a peak in samples collected 18 weeks after the first qRT-PCR-positive sample (Fig. 3 ).
IgG indirect ELISA diagnostic performance
Estimates of IgG indirect ELISA performance were based on samples of defined status. Positive samples (n = 492) for estimating diagnostic sensitivity included samples collected on DPI 14, 17, and 21 (n = 251) from experimentally inoculated pigs and field samples (n = 241) collected from pens after the first PRRSV qRT-PCR-positive result. Negative samples (n = 367) for estimating diagnostic specificity included oral fluid specimens from experimentally inoculated pigs collected on DPI 0 (n = 84) and field samples (n = 283) submitted to the ISU VDL for PRRSV qRT-PCR testing from PRRSV-negative monitored herds. The cumulative S/P results for defined positive and negative oral fluid samples are given in Figure 4 . Mean S/P ratios of negative and positive samples were -0.001 (95% CI: -0.006, 0.002) and 2.751 (95% CI: 2.639, 2.864), respectively. Estimates of diagnostic sensitivity and specificity by S/P ratio cutoff obtained through ROC analysis are shown in Table 2 and Figure 5 . 
Discussion
In the current study, the detection of anti-PRRSV antibodies in oral fluid specimens was evaluated using a commercial PRRSV indirect ELISA a performed using a procedure adapted to the oral fluid matrix. The validity of this approach was supported by prior evidence that pigs, like human beings and other species, produce detectable levels of specific antibodies in oral fluid in response to infection with PRRSV, as well as other pathogens. 30 Essentially, the ELISA procedure was modified to calibrate the reactivity of the assay to the lower concentration of antibody present in oral fluid relative to serum. Specific modifications included larger sample volume, less dilution of the sample, higher secondary antibody concentration, and longer sample incubation. 14 A key step to creating a reproducible test was determining the kit lotspecific dilution of secondary antibody. This was done by titrating the secondary antibody against a 1:30 dilution of positive and negative controls and then calculating the dilution of secondary antibody that matched the OD values for the positive and negative controls in the manufacturer's Certificate of Analysis. This step provided repeatable results and resulted in a cutoff in the oral fluid IgG ELISA that matched the cutoff recommended by the manufacturer for the serum ELISA (S/P ≥ 0.40).
Anti-PRRSV IgM, IgA, and IgG responses were evaluated in pen-based oral fluid samples using isotype-specific ELISAs. Immunoglobulin M, IgA, and IgG were readily detected in populations in which the infection was synchronized among all individuals (i.e., reference standards and experimental samples). However, this was not the case in field samples. The reason for the difference in responses in synchronized versus field samples is unknown, but it may be hypothesized that asynchrony in the spread of PRRSV infection in the field resulted in animals at different stages of the antibody response. Consequently, IgM and IgA from pigs in the early stages of infection would have been diluted by oral fluid from animals not secreting those antibody isotypes. In addition, IgG, both because of its higher concentration and its higher affinity, may have outcompeted IgM and IgA for the antigenic sites available in the ELISA plate. 18, 22 In contrast to IgM and IgA, IgG was readily detected at diagnostically useful levels in reference standards, experimental samples, and field samples for an extended period. That is, IgG was consistently detected in reference standards through the termination of sample collection at DPV 91 and in experimental samples and field samples throughout their respective observation periods (i.e., 21 and 126 days).
Previous reports on anti-PRRSV serum antibody kinetics using an indirect fluorescent antibody test reported that IgM was first detected [5] [6] [7] 20, 26 and IgG was detected 9-11 DPI. 20, 34 Thus, the kinetics of serum IgM and IgG responses reported in the literature and the findings of the current study for oral fluid were similar. In contrast, IgA was first detected by immunoperoxidase monolayer assay in serum at 14 DPI, reached its maximum concentration at 25 DPI, and was undetectable after 35 DPI. 17 The reported detection of IgA in serum was later and shorter compared with the response observed in oral fluid. Overall, the observations for oral fluid are in agreement with general understanding of antibody kinetics in serum and on mucosal surfaces. Likewise, these data are compatible with previous reports that IgA is locally produced by serumderived plasma cells in salivary glands and duct-associated lymphoid tissue, whereas IgM and IgG are primarily derived from serum, with some contribution from local production. 30 The use of pen-based oral fluid specimens, an unusual sample for an antibody ELISA, requires comment because an understanding of the epidemiological and statistical properties of the sample is central to the interpretation and analysis of the assay results. In sampling terminology, an oral fluid sample is best described as a grab sample from a sample unit (pen), where "grab sample" is defined as a sample collected "at a specific point in time and at a specific location" 16 and "sample unit" is the smallest division of the population and the level at which sample size calculations and random sampling procedures are performed. 9, 32, 33 Examples of sample units include "an animal, a group of animals, i.e., a pen, a herd . . . . " 33 Oral fluid ELISA results are amenable to diagnostic interpretation because the pathogen-specific epidemic curve and immune responses of the individual pigs within the pen are highly correlated (dependent). The link with specific time and place provides for the statistical analysis of the results, including analysis of geospatial relationships between pens in the context of the larger population.
A pen-based sample should not be confused with a pooled sample. More universally known as a "composite sample," 10 a pooled sample is created by combining 2 or more sample unit specimens into 1 aliquot for testing, thereby losing sample unit identity in the process. 5 Pooled samples are typically used to screen populations at a lower cost than testing individual samples using a 2-step process termed the Dorfman procedure. 21 A pooled sample could be roughly equivalent to pen-based samples if the sample units were members of the same pen, but this is rarely the case. In fact, the geospatial relationships among sample units in pooled samples are usually unknown. Thus, testing of pooled samples may determine whether the defined analyte is present, but further statistical analyses or epidemiological interpretations are usually limited or impossible because of the loss of sample unit identification. The current study did not evaluate whether the ELISA procedure described could be used for pooled samples. At any rate, given the ease of collecting pen-based samples and the economic utility of ELISA-based testing, it is doubtful that testing pooled oral fluid samples could be justified by the loss of statistical and epidemiological interpretability.
Cumulatively, the present study showed that a commercial serum antibody ELISA a adapted to oral fluid specimens can be used to detect anti-PRRSV antibody. Testing for PRRSV antibody using pen-based oral fluids could provide an efficient, cost-effective approach for monitoring maternal antibody, vaccination compliance, and herd immune parameters in commercial herds and surveillance of PRRSV infections in elimination programs. The successful adaptation of a commercial serum antibody ELISA to the oral fluid matrix suggests that antibody assays for other pathogens could also be modified to this purpose.
